ACETAdicet Bio, Inc.

Nasdaq adicetbio.com


$ 1.52 $ 0.04 (2.68 %)    

Monday, 26-Aug-2024 15:59:50 EDT
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 1.53
$ 1.49
$ 1.52 x 250
-- x --
$ 1.47 - $ 1.55
$ 1.05 - $ 3.77
298,011
na
122.78M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-19-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-15-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-15-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-12-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-12-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-29-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 canaccord-genuity-maintains-buy-on-adicet-bio-maintains-19-price-target

Canaccord Genuity analyst John Newman maintains Adicet Bio (NASDAQ:ACET) with a Buy and maintains $19 price target.

 hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 adicet-bio-says-fda-has-granted-fast-track-designation-to-adi-001-for-potential-treatment-of-relapsedrefractory-class-iii-or-class-iv-lupus-nephritis

Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs intended to treat s...

 hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 adicet-bio-q1-2024-adj-eps-035-beats-039-estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.39) by...

 adicet-bio-announces-poster-presentation-of-adi-270-preclinical-data-at-the-2024-eha-hybrid-congress

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell...

 wedbush-reiterates-outperform-on-adicet-bio-maintains-5-price-target

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $5 price target.

 hc-wainwright--co-maintains-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White maintains Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 adicet-bio-may-offer-and-sell-shares-of-common-stock-having-an-aggregate-offering-price-of-up-to-100m-from-time-to-time

-SEC Filing

 hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

 wedbush-reiterates-outperform-on-adicet-bio-maintains-5-price-target

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $5 price target.

 canaccord-genuity-reiterates-buy-on-adicet-bio-maintains-19-price-target

Canaccord Genuity analyst John Newman reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $19 price target.

 adicet-bio-q4-earnings-insights
Adicet Bio: Q4 Earnings Insights
03/19/2024 21:30:06

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION